| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |